"Brilliant brand · Glorious future"

    On 28 October, the 19th China International Laboratory Medicine and Blood Transfusion Equipment Reagent Expo (CACLP) came to an end at Nanchang Greenland International Expo Center! More than 1,400 exhibitors from nearly 20 countries and regions around the world participated in this grand event.

Qingdao Henderson Biological Technology Co.,Ltd is committed to making IVD develop energetically. The unique platform model integrating R&D, production and verification is deeply favored and recognized by our customers, our company continues to improve industrial technology exchanges and expansion to better adapt to market demand. 

    The Henderson team welcomes the exhibition with a full spirit. Our business personnel communicated cordially with visitors and introduced the products professionally to meet the needs of different customers. As an IVD raw material supplier, Henderson has been constantly exploring from R&D to production, and has achieved more than 500 kinds of antigens, antibodies, enzymes and other products, among which infectious diseases, drugs, myocardial markers, tumor markers and pet products have attracted the attention of both new and old customers.

    The elites of the industry gathered together at this in vitro diagnostic professional event integrating R&D, professionalism, scale and influence, Henderson made full use of its own advantages to introduce products and R&D experience to visitors in detail, so that every customer can return with a rewarding experience and will not come in vain.

    After years of development, Henderson has become one of the few companies in China that can independently develop and produce antigens and antibodies, and our products include infectious disease series, inflammation series, cardiovascular and cerebrovascular disease series, drug series, myocardial marker series, tumor marker series, scientific research antibody series and many other fields, including mouse anti-new crown N protein monoclonal antibody, mouse anti-new crown S1 protein monoclonal antibody, new crown N protein antigen, cardiac troponin I (cTnI), carbohydrate antigen (CA125), etc., which can be widely used in multiple platforms such as chemiluminescence verification platform, hierarchical platform (fluorescence, colloidal gold), immunoturbidimetric verification platform, and molecular diagnostic technology platform. At the same time, Henderson provides one-stop solutions for scientific research, production, and after-sales to effectively improve accurate diagnostic technology and help the competitive advantage of core biological raw materials.

   Along the way, Henderson is grateful for your support, making our future more hopeful. In the future, Henderson will keep innovating and developing, and provide high-quality services to new and old customers with high-quality products, professional technology and after-sales service.

  Henderson looks forward to seeing you again next year! !